Sign In
Last checked at 
26 Nov 2008 12:15
|
For immediate release |
26 November 2008 |
Futura Medical plc
("Futura" or "the Group" or "the Company")
Temporary Suspension of Trading on AIM
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, notes the recent upwards movement in the Company's share price and has requested a temporary suspension of trading in its shares on AIM pending an announcement. Futura confirms that it expects to make an announcement shortly on the Competent Authority's regulatory opinion on CSD500, the Company's innovative condom.
For any further information please contact:
|
Futura Medical plc |
|
|
James Barder, Chief Executive |
Tel: +44 (0) 1483 685 670 |
|
mail to: james.barder@futuramedical.co.uk |
www.futuramedical.co.uk |
|
Canaccord Adams |
|
|
Ryan Gaffney / Adria Da Breo Richards |
Tel: +44 (0) 20 7050 6500 |
|
For media enquiries please contact: |
|
|
Buchanan Communications |
|
|
Mark Court / Rebecca Skye Dietrich |
Tel: +44 (0) 20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.co.uk
Follow the stocks
